Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Netflix
NFLX
|
+$385M |
| 2 |
Microsoft
MSFT
|
+$368M |
| 3 |
Berkshire Hathaway Class A
BRK.A
|
+$298M |
| 4 |
Delta Air Lines
DAL
|
+$208M |
| 5 |
Carnival Corporation Ltd
CCL
|
+$203M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$1.34B |
| 2 |
Tesla
TSLA
|
+$353M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$303M |
| 4 |
NVIDIA
NVDA
|
+$290M |
| 5 |
Boeing
BA
|
+$286M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.37% |
| 2 | Healthcare | 18.47% |
| 3 | Consumer Discretionary | 12.41% |
| 4 | Consumer Staples | 10.13% |
| 5 | Industrials | 9.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3076
Q32 Bio
QTTB
$452M
| $211K | ﹤0.01% |
10,000
-6,617
| -40% | -$135K |
|
3077
Global X US Infrastructure Development ETF
PAVE
$14.3B
| $210K | ﹤0.01% |
6,900
-27,000
| -80% | -$852K |
|
|
SOHO
3078
DELISTED
Sotherly Hotels
SOHO
| $209K | ﹤0.01% |
123,712
+2,836
| +2% | +$5.68K |
|
3079
HF Foods Group
HFFG
$99.2M
| $208K | ﹤0.01% |
52,500
+9,600
| +22% | +$45.7K |
|
3080
JPMorgan US Quality Factor ETF
JQUA
$8.64B
| $208K | ﹤0.01% |
4,800
-14,000
| -74% | -$625K |
|
3081
State Street SPDR S&P 400 Mid Cap Value ETF
MDYV
$2.9B
| $208K | ﹤0.01% |
+3,200
| New | +$220K |
|
|
AHG
3082
Akso Health Group
AHG
$1.07B
| $207K | ﹤0.01% |
199,398
-15,000
| -7% | -$8.6K |
|
|
TOUR
3083
Tuniu
TOUR
$54.4M
| $207K | ﹤0.01% |
17,233
-380
| -2% | -$5.28K |
|
3084
Femasys
FEMY
$7.04M
| $206K | ﹤0.01% |
3,456
+2,881
| +501% | +$30.1K |
|
3085
Auburn National Bancorp
AUBN
$91.6M
| $205K | ﹤0.01% |
9,541
-600
| -6% | -$13.1K |
|
3086
BGSF Inc
BGSF
$59.2M
| $205K | ﹤0.01% |
21,300
-9,638
| -31% | -$94.8K |
|
3087
Lisata Therapeutics
LSTA
$10M
| $205K | ﹤0.01% |
95,722
+2,400
| +3% | +$6.67K |
|
3088
VanEck Agribusiness ETF
MOO
$980M
| $205K | ﹤0.01% |
2,600
-2,639
| -50% | -$220K |
|
|
KE
3089
Kimball Electronics
KE
$640M
| $203K | ﹤0.01% |
7,425
-15,400
| -67% | -$440K |
|
|
ESPR
3090
DELISTED
Esperion Therapeutics
ESPR
| $202K | ﹤0.01% |
206,156
+91,856
| +80% | +$133K |
|
|
WKME
3091
DELISTED
WalkMe Ltd. Ordinary Shares
WKME
| $202K | ﹤0.01% |
21,300
+1,400
| +7% | +$12.6K |
|
|
GOCO
3092
DELISTED
GoHealth
GOCO
| $201K | ﹤0.01% |
13,872
-2,000
| -13% | -$34.4K |
|
3093
The Beachbody Company
BODI
$49.9M
| $201K | ﹤0.01% |
13,618
+2,252
| +20% | +$45.2K |
|
3094
SIFCO Industries
SIF
$126M
| $200K | ﹤0.01% |
54,534
-9,900
| -15% | -$27K |
|
3095
Mueller Water Products
MWA
$3.97B
| $198K | ﹤0.01% |
+15,600
| New | +$225K |
|
3096
Ranpak Holdings
PACK
$469M
| $197K | ﹤0.01% |
+36,300
| New | +$199K |
|
3097
Recon Technology
RCON
$2.24M
| $196K | ﹤0.01% |
35,206
-17,383
| -33% | -$113K |
|
3098
Relmada Therapeutics
RLMD
$507M
| $196K | ﹤0.01% |
65,275
-67,497
| -51% | -$200K |
|
|
LYRA
3099
DELISTED
LYRA THERAPEUTICS INC
LYRA
| $195K | ﹤0.01% |
996
-424
| -30% | -$75.8K |
|
3100
CuriosityStream
CURI
$216M
| $194K | ﹤0.01% |
272,900
+12,100
| +5% | +$10.6K |
|
Similar funds
Jim Simons's Q3 2023 Portfolio in Review
As of Q3 2023, Jim Simons held 4,329 positions worth $58.7B, down 15% from $69.4B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Jim Simons withdrew a net $8.34B in Q3 2023, closing 713 positions and reducing 1,794 holdings. Its most notable exit was Chevron, an estimated $185M position sold in full.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Jim Simons opened a new position in D.R. Horton worth $125M.
- Jim Simons's largest Q3 2023 buy was D.R. Horton: 1,159,438 shares worth $125M.
- Jim Simons added most to Netflix in Q3 2023, an estimated $385M increase.
- Jim Simons's biggest Q3 2023 reduction was Meta Platforms (Facebook), cutting an estimated $1.34B.
- Jim Simons fully exited Chevron in Q3 2023, selling an estimated $185M.
- Jim Simons's ten largest holdings make up 12% of its $58.7B portfolio in Q3 2023.
- Jim Simons opened 464 new positions and closed 713 in Q3 2023.
- Jim Simons's portfolio value fell 15% quarter-over-quarter to $58.7B.
Based on Renaissance Technologies's 13F filing for Q3 2023, filed 14 Nov 2023.